These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 7437974)

  • 21. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
    Van Durme JP
    Acta Cardiol Suppl; 1980; (25):121-5. PubMed ID: 6990664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of arrhythmia due to heart surgery by means of mexiletine].
    Kujat R; Dittrich H
    Med Welt; 1979 Oct; 30(40):1485-8. PubMed ID: 502822
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative anti-arrhythmic efficacy of mexiletine, procainamide and tolamolol in patients with symptomatic ventricular arrhythmias.
    Jewitt DE; Jackson G; McComish M
    Postgrad Med J; 1977; 53 Suppl 1():158-62. PubMed ID: 327454
    [No Abstract]   [Full Text] [Related]  

  • 24. Ventricular arrhythmia and tetralogy of Fallot repair with transannular patch.
    Ozkan S; Akay T; Gültekin B; Varan B; Tokel K; Aşlamaci S
    Anadolu Kardiyol Derg; 2005 Dec; 5(4):297-301. PubMed ID: 16330396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proceedings: Comparison of mexiletine and procainamide in prevention of recurrent ventricular arrhythmias after acute myocardial infarction.
    Campbell RW; Talbot RG; Dolder M; Prescott L; Julian DG
    Br Heart J; 1975 Jul; 37(7):779. PubMed ID: 1156488
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mexiletine in supraventricular arrhythmias].
    Dienstl F
    Adv Clin Pharmacol; 1978; 16():103-11. PubMed ID: 685747
    [No Abstract]   [Full Text] [Related]  

  • 27. [Efficacy of mexiletine in the long-term treatment of exertion arrhythmia].
    Pesciatini F; Lazzaroni A; Mancini R; Ugolini C; Cerri B
    Minerva Cardioangiol; 1985; 33(1-2):33-9. PubMed ID: 3874375
    [No Abstract]   [Full Text] [Related]  

  • 28. Incidence and severity of arrhythmias and conduction disturbance after repair of tetralogy of Fallot.
    Günal N; Tokel K; Kahramanyol O; Ozer S; Celiker A; Ekici E; Yurdakul Y; Kutsal A
    Turk J Pediatr; 1997; 39(4):491-8. PubMed ID: 9433151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical study of the ventricular anti-arrhythmia effects of oral and injectable mexiletine].
    Fauchier JP; Charbonnier B; Latour F; Brochier M; Raynaud R
    Ann Cardiol Angeiol (Paris); 1978; 27(2):173-8. PubMed ID: 655605
    [No Abstract]   [Full Text] [Related]  

  • 30. Mexiletine for arrhythmias.
    Med Lett Drugs Ther; 1986 Jul; 28(717):65-6. PubMed ID: 3523180
    [No Abstract]   [Full Text] [Related]  

  • 31. Ventricular arrhythmias after acute myocardial infarction treated with procainamide or mexiletine.
    Campbell RW; Dolder MA; Prescott LF; Talbot RG; Murray A; Julian DG
    Postgrad Med J; 1977; 53 Suppl 1():150-3. PubMed ID: 327453
    [No Abstract]   [Full Text] [Related]  

  • 32. [Efficacy of mexiletine in the treatment of ventricular arrhythmia in patients with conduction disorders and sick sinus syndrome].
    González Zuelgaray J; Nieves E; Fernández R; Posse RA
    Medicina (B Aires); 1982; 42(5):483-7. PubMed ID: 7169943
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative evaluation of mexiletine and propafenone by dynamic electrocardiography].
    Marzegalli M; Bernasconi M; Brambilla G; Micheletti T; Potenza S; Regalia F; Barbaresco L; Bossi M
    G Ital Cardiol; 1984 May; 14(5):352-6. PubMed ID: 6468816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tetralogy of Fallot: historical lessons.
    Fuster V; Griepp RB
    Mt Sinai J Med; 1985 Sep; 52(7):534-40. PubMed ID: 3877871
    [No Abstract]   [Full Text] [Related]  

  • 35. The development of mexiletine in the treatment of cardiac arrhythmias.
    Nimmo J
    Postgrad Med J; 1977; 53 Suppl 1():120-3. PubMed ID: 876943
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effectiveness of mexiletine in arrhythmia of effort].
    Zacà F; Cremonesi A; Pagliarani PL; Guelfi P; Bugiardini R; Lasagna I; Ghinelli M; Luciani G
    Minerva Cardioangiol; 1981 Nov; 29(11):655-60. PubMed ID: 6173818
    [No Abstract]   [Full Text] [Related]  

  • 37. The roles of chronic pressure and volume overload states in induction of arrhythmias: an animal model of physiologic sequelae after repair of tetralogy of Fallot.
    Zeltser I; Gaynor JW; Petko M; Myung RJ; Birbach M; Waibel R; Ittenbach RF; Tanel RE; Vetter VL; Rhodes LA
    J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1542-8. PubMed ID: 16307996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the antiarrhythmic activity of mexiletine and lorcainide on ventricular arrhythmias.
    Meinertz T; Kasper W; Stengel E; Waldecker B; Löllgen H; Jähnchen E; Bechtold H; Just J
    Z Kardiol; 1982 Jan; 71(1):35-8. PubMed ID: 7039160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term outcome of surgically treated teratology of Fallot].
    Ben Khalfallah A; Annabi N; Ousji M
    Tunis Med; 2004 Jan; 82 Suppl 1():88-93. PubMed ID: 15127696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mexiletine for ventricular arrhythmias.
    Drug Ther Bull; 1976 Oct; 14(21):83-4. PubMed ID: 976096
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.